Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength [Yahoo! Finance]
Sana Biotechnology, Inc. (SANA)
Company Research
Source: Yahoo! Finance
analyst Alec Stranahan reaffirmed a Buy rating on Sana Biotechnology (NASDAQ: SANA) and set a price target of $6.00. Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength Pressmaster/Shutterstock.com TD Cowen analyst Marc Frahm also maintained a Buy rating on Sana Biotechnology Inc., citing the company's decision to focus on its high-potential SC451 program while pausing allogeneic CAR T development to conserve cash, extending its runway into late 2026. Management has gained FDA clarity on key steps toward an IND filing for SC451 in 2026 and is advancing its SG293 program, with an IND possible by 2027. With a cash position of $170 million, these moves highlight Sana's strategic focus and financial stability, supporting Frahm's bullish stance. Earlier, on October 30 analysts at Citizens initiated coverage of Sana Biotechnology Inc. with a Market Perform rating. The positive stance comes on the heels of EMJ Capital Eric Jackson reiterating that
Show less
Read more
Impact Snapshot
Event Time:
SANA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SANA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SANA alerts
High impacting Sana Biotechnology, Inc. news events
Weekly update
A roundup of the hottest topics
SANA
News
- Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to-Date Share Price Gains [Yahoo! Finance]Yahoo! Finance
- Sana Biotechnology to Present at December 2025 Investor ConferencesGlobeNewswire
- Sana Biotechnology (NASDAQ:SANA) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SANA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StreMarketBeat
- Can Sana Biotechnology's (SANA) Leaner Cost Structure Strengthen Its Long-Term Competitive Position? [Yahoo! Finance]Yahoo! Finance
- Assessing Sana Biotechnology's (SANA) Valuation After Strategic Refocus and Encouraging Clinical Updates [Yahoo! Finance]Yahoo! Finance
SANA
Earnings
- 8/11/25 - Beat
SANA
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- SANA's page on the SEC website